HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

olaparib

an antineoplastic agent, Poly(ADP-ribose) Polymerase inhibitor
Also Known As:
AZD 2281; AZD-2281; AZD221; AZD2281; Lynparza
Networked: 1723 relevant articles (242 outcomes, 493 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. O'Connor, Mark J: 31 articles (01/2022 - 06/2008)
2. Friedlander, Michael: 26 articles (01/2022 - 07/2010)
3. Gourley, Charlie: 23 articles (08/2022 - 05/2010)
4. Banerjee, Susana: 23 articles (12/2021 - 10/2013)
5. Colombo, Nicoletta: 20 articles (01/2022 - 01/2015)
6. Lord, Christopher J: 19 articles (11/2021 - 09/2012)
7. Ashworth, Alan: 17 articles (01/2022 - 07/2009)
8. Scambia, Giovanni: 16 articles (01/2022 - 04/2018)
9. Vergote, Ignace: 16 articles (01/2022 - 02/2012)
10. Ledermann, Jonathan A: 16 articles (12/2021 - 06/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Breast Neoplasms (Breast Cancer)
4. Prostatic Neoplasms (Prostate Cancer)
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Poly(ADP-ribose) Polymerase Inhibitors
2. Platinum
3. Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
4. Bevacizumab (Avastin)
5. niraparib
6. Paclitaxel (Taxol)
7. rucaparib
8. talazoparib
9. olaparib
10. abiraterone

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Castration
4. Radiotherapy
5. Immunotherapy